Literature DB >> 31712427

RAMP3 determines rapid recycling of atypical chemokine receptor-3 for guided angiogenesis.

Duncan I Mackie1, Natalie R Nielsen1, Matthew Harris2, Smriti Singh1, Reema B Davis1, Danica Dy1, Graham Ladds2, Kathleen M Caron3.   

Abstract

Receptor-activity-modifying proteins (RAMPs) are single transmembrane-spanning proteins which serve as molecular chaperones and allosteric modulators of G-protein-coupled receptors (GPCRs) and their signaling pathways. Although RAMPs have been previously studied in the context of their effects on Family B GPCRs, the coevolution of RAMPs with many GPCR families suggests an expanded repertoire of potential interactions. Using bioluminescence resonance energy transfer-based and cell-surface expression approaches, we comprehensively screen for RAMP interactions within the chemokine receptor family and identify robust interactions between RAMPs and nearly all chemokine receptors. Most notably, we identify robust RAMP interaction with atypical chemokine receptors (ACKRs), which function to establish chemotactic gradients for directed cell migration. Specifically, RAMP3 association with atypical chemokine receptor 3 (ACKR3) diminishes adrenomedullin (AM) ligand availability without changing G-protein coupling. Instead, RAMP3 is required for the rapid recycling of ACKR3 to the plasma membrane through Rab4-positive vesicles following either AM or SDF-1/CXCL12 binding, thereby enabling formation of dynamic spatiotemporal chemotactic gradients. Consequently, genetic deletion of either ACKR3 or RAMP3 in mice abolishes directed cell migration of retinal angiogenesis. Thus, RAMP association with chemokine receptor family members represents a molecular interaction to control receptor signaling and trafficking properties.

Entities:  

Keywords:  G-protein–coupled receptors; chemokine receptors; endosomal sorting; guided cell migration; receptor-activity–modifying proteins

Mesh:

Substances:

Year:  2019        PMID: 31712427      PMCID: PMC6883789          DOI: 10.1073/pnas.1905561116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.

Authors:  L M McLatchie; N J Fraser; M J Main; A Wise; J Brown; N Thompson; R Solari; M G Lee; S M Foord
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

2.  Generation and dynamics of an endogenous, self-generated signaling gradient across a migrating tissue.

Authors:  Gayatri Venkiteswaran; Stephen W Lewellis; John Wang; Eric Reynolds; Charles Nicholson; Holger Knaut
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

3.  A Controlled Trial of Erenumab for Episodic Migraine.

Authors:  Peter J Goadsby; Uwe Reuter; Yngve Hallström; Gregor Broessner; Jo H Bonner; Feng Zhang; Sandhya Sapra; Hernan Picard; Daniel D Mikol; Robert A Lenz
Journal:  N Engl J Med       Date:  2017-11-30       Impact factor: 91.245

4.  ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin.

Authors:  Friederike Saaber; Dagmar Schütz; Elke Miess; Philipp Abe; Srinidhi Desikan; Praveen Ashok Kumar; Sara Balk; Ke Huang; Jean Martin Beaulieu; Stefan Schulz; Ralf Stumm
Journal:  Cell Rep       Date:  2019-02-05       Impact factor: 9.423

5.  Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age.

Authors:  Ryan Dackor; Kim Fritz-Six; Oliver Smithies; Kathleen Caron
Journal:  J Biol Chem       Date:  2007-04-30       Impact factor: 5.157

Review 6.  The expanding repertoire of receptor activity modifying protein (RAMP) function.

Authors:  Klara R Klein; Brooke C Matson; Kathleen M Caron
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-01-06       Impact factor: 8.250

7.  CXCL12 enhances human neural progenitor cell survival through a CXCR7- and CXCR4-mediated endocytotic signaling pathway.

Authors:  Bing Zhu; Dongsheng Xu; Xiaobei Deng; Qiang Chen; Yunlong Huang; Hui Peng; Yuju Li; Beibei Jia; Wallace B Thoreson; Wenjun Ding; Jianqing Ding; Lixia Zhao; Yi Wang; Kristin Leland Wavrin; Shumin Duan; Jialin Zheng
Journal:  Stem Cells       Date:  2012-11       Impact factor: 6.277

Review 8.  Immune regulation by atypical chemokine receptors.

Authors:  Robert J B Nibbs; Gerard J Graham
Journal:  Nat Rev Immunol       Date:  2013-11       Impact factor: 53.106

9.  RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling.

Authors:  Jaimini Cegla; Ben J Jones; James V Gardiner; David J Hodson; Thomas Marjot; Emma R McGlone; Tricia M Tan; Stephen R Bloom
Journal:  Endocrinology       Date:  2017-08-01       Impact factor: 4.736

10.  Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor.

Authors:  Yi-Lynn Liang; Maryam Khoshouei; Giuseppe Deganutti; Alisa Glukhova; Cassandra Koole; Thomas S Peat; Mazdak Radjainia; Jürgen M Plitzko; Wolfgang Baumeister; Laurence J Miller; Deborah L Hay; Arthur Christopoulos; Christopher A Reynolds; Denise Wootten; Patrick M Sexton
Journal:  Nature       Date:  2018-09-12       Impact factor: 49.962

View more
  18 in total

1.  Deletion of atypical chemokine receptor 3 (ACKR3) increases immune cells at the fetal-maternal interface.

Authors:  Kelsey E Quinn; Brooke C Matson; Kathleen M Caron
Journal:  Placenta       Date:  2020-04-22       Impact factor: 3.481

Review 2.  Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases.

Authors:  Vincent Duval; Paul Alayrac; Jean-Sébastien Silvestre; Angélique Levoye
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

3.  Biochemical characterization of G protein coupling to calcitonin gene-related peptide and adrenomedullin receptors using a native PAGE assay.

Authors:  Amanda M Roehrkasse; Margaret L Warner; Jason M Booe; Augen A Pioszak
Journal:  J Biol Chem       Date:  2020-06-02       Impact factor: 5.157

Review 4.  Dawn of a New RAMPage.

Authors:  D Stephen Serafin; Natalie R Harris; Natalie R Nielsen; Duncan I Mackie; Kathleen M Caron
Journal:  Trends Pharmacol Sci       Date:  2020-02-27       Impact factor: 14.819

Review 5.  Mechanisms of selective G protein-coupled receptor localization and trafficking.

Authors:  Jennifer M Kunselman; Joshua Lott; Manojkumar A Puthenveedu
Journal:  Curr Opin Cell Biol       Date:  2021-05-07       Impact factor: 8.386

6.  Ligand-competent fractalkine receptor is expressed on exosomes.

Authors:  Eun Jeong Park; Phyoe Kyawe Myint; Michael G Appiah; Patsorn Worawattananutai; Janjira Inprasit; Onmanee Prajuabjinda; Zay Yar Soe; Arong Gaowa; Eiji Kawamoto; Motomu Shimaoka
Journal:  Biochem Biophys Rep       Date:  2021-02-02

Review 7.  Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.

Authors:  Ramiro Vázquez; Maria E Riveiro; Caroline Berenguer-Daizé; Anthony O'Kane; Julie Gormley; Olivier Touzelet; Keyvan Rezai; Mohamed Bekradda; L'Houcine Ouafik
Journal:  Front Oncol       Date:  2021-01-06       Impact factor: 6.244

8.  Discovery of a First-in-Class Potent Small Molecule Antagonist against the Adrenomedullin-2 Receptor.

Authors:  Paris Avgoustou; Ameera B A Jailani; Jean-Olivier Zirimwabagabo; Matthew J Tozer; Karl R Gibson; Paul A Glossop; James E J Mills; Roderick A Porter; Paul Blaney; Peter J Bungay; Ning Wang; Alice P Shaw; Kamilla J A Bigos; Joseph L Holmes; Jessica I Warrington; Timothy M Skerry; Joseph P A Harrity; Gareth O Richards
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-25

9.  Temporal and spatial expression of adrenomedullin and its receptors in the porcine uterus and peri-implantation conceptuses.

Authors:  Sudikshya Paudel; Bangmin Liu; Magdalina J Cummings; Kelsey E Quinn; Fuller W Bazer; Kathleen M Caron; Xiaoqiu Wang
Journal:  Biol Reprod       Date:  2021-10-11       Impact factor: 4.161

10.  Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer.

Authors:  Haoran Feng; Kun Liu; Xiaonan Shen; Juyong Liang; Changgang Wang; Weihua Qiu; Xi Cheng; Ren Zhao
Journal:  Cell Death Dis       Date:  2020-10-24       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.